PYC Therapeutics Ltd
F:PH7
PYC Therapeutics Ltd
F:PH7
Price:
0.065
EUR
Market Closed
Market Cap:
€290.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PYC Therapeutics Ltd
F:PH7
|
AU |
|
IDI SCA
PAR:IDIP
|
FR |
|
Mader Group Ltd
ASX:MAD
|
AU |
|
Elcora Advanced Materials Corp
F:ELM0
|
CA |
|
G
|
Glanbia PLC
OTC:GLAPY
|
IE |
|
D
|
DEME Group NV
F:MT0
|
BE |
|
1414 Degrees Ltd
ASX:14D
|
AU |
|
H
|
Hang Lung Group Ltd
SWB:HLU
|
HK |
|
Dominion Hosting Holding SpA
MIL:DHH
|
IT |
|
G
|
Geox SpA
XMUN:GHH
|
IT |
|
Grupo Ezentis SA
F:RDT1
|
ES |
|
Cleantech Vanadium Mining Corp
XTSX:CTV
|
CA |
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
Corbion NV
AEX:CRBN
|
NL |
|
A
|
Ascopiave SpA
SWB:AVA
|
IT |
|
H
|
Hana 33 Special Purpose Acquisition Co
KOSDAQ:475250
|
KR |
|
T
|
TechL Co Ltd
KOSDAQ:064520
|
KR |
Multiples-Based Value
The Multiples-Based Value for 
PYC Therapeutics Ltd (PH7) under the Base Case is hidden
EUR.
Compared with the current market price of 0.065 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PH7 Multiples-Based Value
LOCKED